<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03181932</url>
  </required_header>
  <id_info>
    <org_study_id>SAV005-04</org_study_id>
    <nct_id>NCT03181932</nct_id>
  </id_info>
  <brief_title>A Study of AeroVanc for the Treatment of MRSA Infection in CF Patients</brief_title>
  <official_title>A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Savara Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Savara Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a multi-center, randomized phase III study to evaluate the clinical
      effectiveness of AeroVanc in persistent MRSA in patients with Cystic Fibrosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a Phase III, randomized, multicenter, double-blind, placebo-controlled,
      parallel-group study to examine the safety and efficacy of AeroVanc in the treatment of
      persistent Methicillin resistant Staphylococcus aureus (MRSA) lung infection in patients
      diagnosed with cystic fibrosis (CF). After the Screening period to confirm study eligibility,
      subjects will be randomly assigned in a blinded fashion to receive either AeroVanc 30 mg
      twice daily (BID), or placebo BID (1:1 active to placebo) by inhalation for 24 weeks or 3
      dosing cycles (Period 1). Upon completion of Period 1, subjects will receive open-label
      AeroVanc 30 mg BID for an additional 24 weeks or 3 dosing cycles (Period 2), to evaluate
      long-term safety of AeroVanc. A dosing cycle is defined as 28 days of treatment followed by
      28 days of observation.

      Subjects on a cyclical on/off anti-Pseudomonal antibiotic regimen will enter the Screening
      period at a time such that the Baseline visit coincides with the end of their
      anti-Pseudomonas antibiotic cycle. Study drug will thereby be administered during the
      off-cycle, and subjects can then resume anti-Pseudomonal therapy during the 28-day
      observation period. Subjects continuing alternating anti-Pseudomonal therapy can continue
      their treatment during the study drug administration, and observation period.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 26, 2017</start_date>
  <completion_date type="Anticipated">December 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The mean absolute change from baseline in FEV1 percent predicted. The endpoint will be analyzed sequentially at Week 4 (end of Cycle 1) and at Week 20 (end of Cycle 3).</measure>
    <time_frame>Week 4 and 20 of treatment period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to use of another antibiotic medication (oral, IV, and/or inhaled) for pulmonary infection</measure>
    <time_frame>Week 20 of treatment period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of successful response cycles a subject achieves over Period 1</measure>
    <time_frame>Weeks 4, 12, and 20</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative change from Baseline in FEV1 percent predicted</measure>
    <time_frame>Weeks 4 and 20</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in the Cystic Fibrosis Questionnaire-Revised (CFQ-R) scores</measure>
    <time_frame>Weeks 4 and 20</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in the Cystic Fibrosis Respiratory Symptom Diary-Chronic Respiratory Symptom Score (CFRSD-CRISS) scores</measure>
    <time_frame>Weeks 4 and 20</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Changes from Baseline in EQ-5D-5L/EQ-5Dy scores</measure>
    <time_frame>Weeks 4 and 20</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from Baseline in MRSA sputum density</measure>
    <time_frame>Weeks 4 and 20</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change from Baseline in body weight</measure>
    <time_frame>Weeks 8 and 24</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>MRSA</condition>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Vancomycin inhalation powder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>30 mg twice daily (BID)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo inhalation powder</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Matching placebo inhaled twice daily (BID)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vancomycin inhalation powder</intervention_name>
    <description>There will be 200 patients treated with Vancomycin inhalation powder or placebo (1:1 active to placebo).</description>
    <arm_group_label>Vancomycin inhalation powder</arm_group_label>
    <other_name>AeroVanc</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo inhalation powder</intervention_name>
    <description>There will be 200 patients treated with Vancomycin inhalation powder or placebo (1:1 active to placebo).</description>
    <arm_group_label>Placebo inhalation powder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects ≥ 6 years of age at time of Informed Consent Form (ICF) or Assent Form
             signing.

          2. Confirmed diagnosis of CF, determined by having clinical features consistent with the
             CF phenotype, plus one of the following:

               1. Positive sweat chloride test (value ≥ 60 mEq/L),

               2. Genotype with 2 mutations consistent with CF (ie, a mutation in each of the
                  cystic fibrosis transmembrane conductance regulator [CFTR] genes).

          3. Positive sputum culture or a throat swab culture for MRSA at Screening.

          4. In addition to the Screening sample, have at least 2 prior sputum or throat swab
             cultures positive for MRSA, of which at least 1 sample is more than 6 months prior to
             Screening. At least 50% of all cultures (sputum or throat swab culture) collected over
             the previous 1 year must have tested positive for MRSA.

          5. Forced expiratory volume in 1 second (FEV1) ≥ 30% and ≤ 90% of predicted that is
             normal for age, gender, race, and height, using the Global Lung Function Initiative
             (GLI) equation.

          6. At least 1 episode of acute pulmonary infection treated with non-maintenance
             antibiotics within 12 months prior to the Baseline visit. (Initiation of treatment
             with intermittent inhaled anti-Pseudomonal therapy will not qualify as treatment with
             non-maintenance antibiotics).

          7. If female of childbearing potential, an acceptable method of contraception must be
             used during the study and must be combined with a negative pregnancy test obtained
             during Screening; male subjects who are non-sterile (ie, male who has not been
             sterilized by vasectomy for at least 6 months) must be willing to use an acceptable
             method of contraception during the study.

             For purposes of this study, the Sponsor defines &quot;acceptable methods of contraception&quot;
             as:

               1. Oral birth control pills administered for at least 1 monthly cycle prior to
                  administration of the study drug.

               2. A synthetic progestin implanted rod (eg, Implanon®) for at least 1 monthly cycle
                  prior to the study drug administration but not beyond the 4th successive year
                  following insertion.

               3. Intrauterine devices (IUDs), inserted by a qualified clinician for at least 1
                  monthly cycle prior to study drug administration.

               4. Medroxyprogesterone acetate (eg, Depo-Provera®) administered for a minimum of 1
                  monthly cycle prior to administration of the study drug and continuing through 1
                  month following study completion.

               5. Hysterectomy or surgical sterilization.

               6. Abstinence.

               7. Double barrier method (diaphragm with spermicidal gel or condoms with
                  contraceptive foam).

          8. Able and willing to comply with the protocol, including availability for all scheduled
             study visits and able to perform all techniques necessary to use the AeroVanc inhaler
             and measure lung function.

          9. Agree not to smoke during any part of the clinical trial (Screening visit through end
             of study).

         10. Subjects with a P. aeruginosa co-infection must either be stable on a regular
             suppression regimen of inhaled antibiotics or must be, in the opinion of the
             Investigator, stable despite the lack of such treatment.

        Exclusion Criteria:

          1. Use of anti-MRSA treatments prescribed as maintenance therapy (intravenous [IV] or
             inhaled treatment within 28 days; oral treatment within 14 days) during the Screening
             period, prior to the Baseline visit.

          2. Use of non-maintenance antibiotic for pulmonary infection or extrapulmonary MRSA
             infection (IV or inhaled antibiotic within 28 days; oral antibiotic within 14 days)
             during the Screening period, prior to the Baseline visit.

          3. History of previous allergies or sensitivity to vancomycin, or other component(s) of
             the study drug or placebo except for a history of red-man syndrome.

          4. Inability to tolerate inhaled products.

          5. First time sputum culture or throat swab culture yielding B. cepacia, or
             nontuberculous Mycobacteria in the previous 6 months to Screening.

          6. History of lung or other solid organ transplantation or currently on the list to
             receive lung or other solid organ transplantation.

          7. Resistance to vancomycin at Screening (vancomycin resistant Staphylococcus aureus
             [VRSA], or vancomycin intermediate resistant Staphylococcus aureus [VISA], with
             minimum inhibitory concentration [MIC] ≥ 8 mcg/mL).

          8. Oral corticosteroids in doses exceeding 10 mg prednisone per day or 20 mg prednisone
             every other day, or equipotent doses of other corticosteroids.

          9. Changes in antimicrobial, bronchodilator, anti-inflammatory or corticosteroid
             medications within 14 days prior to the Baseline visit.

         10. Abnormal laboratory findings or other findings or medical history at Screening that,
             in the Investigator's opinion, would compromise the safety of the subject or the
             quality of the study data.

         11. Inability to tolerate inhalation of a short acting beta2 agonist

         12. SpO2 &lt;90% at Screening.

         13. Changes in physiotherapy technique or physiotherapy scheduled within 1 week of the
             Baseline visit.

         14. Administration of any investigational drug or device within 4 weeks prior to the
             Screening visit and during the study

         15. Female with positive pregnancy test result during Screening, pregnant (or intends to
             become pregnant), lactating or intends to breastfeed during the study.

         16. Renal insufficiency, defined as creatinine clearance &lt; 50 mL/min using the
             Cockcroft-Gault equation for adults or Schwartz equation for children at the Screening
             visit.

         17. Abnormal liver function, defined as ≥ 4x upper limit of normal (ULN), of serum
             aspartate aminotransferase (AST) or serum alanine aminotransferase (ALT), or known
             cirrhosis at Screening.

         18. Diagnosed with clinically significant hearing loss.

         19. History of positive result for human immunodeficiency virus (HIV), hepatitis B virus
             (HBV) or hepatitis C virus (HCV).

         20. Planned hospitalizations for prophylaxis antibiotic treatment within 28 days prior to
             Baseline visit or during the double-blind period (Period 1).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Flume, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jessica Jackson</last_name>
    <phone>832-231-6283</phone>
    <email>jessica.jackson@savarapharma.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pulmonary Associates of Mobile</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liz Knight</last_name>
      <phone>251-631-3023</phone>
      <email>eknight@lungmds.com</email>
    </contact>
    <investigator>
      <last_name>Lawrence Sindel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Phoenix Children's Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalia Argel</last_name>
      <phone>602-933-0343</phone>
      <email>Nargel@phoenixchildrens.com</email>
    </contact>
    <investigator>
      <last_name>Gerald Gong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Hicks</last_name>
      <phone>501-686-5527</phone>
      <email>hickskathleent@uams.edu</email>
    </contact>
    <investigator>
      <last_name>Rajani Jagana, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Miller Childrens Hospital MemorialCare Health System Pediatric Pulmonology</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marielou Keuth</last_name>
      <phone>562-933-5608</phone>
      <email>mkeuth@memorialcare.org</email>
    </contact>
    <investigator>
      <last_name>Cyrus Shahrairy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California Keck Medical Center of USC</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynn Fukushima</last_name>
      <phone>323-409-5383</phone>
      <email>Lynn.fukushima@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Adupa Rao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UC Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaitlyn Kirk</last_name>
      <phone>916-734-8686</phone>
      <email>kkirk@ucdavis.edu</email>
    </contact>
    <investigator>
      <last_name>Brian Morrissey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Cross</last_name>
      <phone>720-777-4645</phone>
      <email>Mary.Cross@childrenscolorado.org</email>
    </contact>
    <investigator>
      <last_name>Edith Zemanick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Jewish Health Adult Cystic Fibrosis Center</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terri Herrud</last_name>
      <phone>303-270-2827</phone>
      <email>HerrudT@NJHealth.org</email>
    </contact>
    <investigator>
      <last_name>Sherstin Lommatzch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida Pediatrics</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Baker</last_name>
      <phone>352-273-5417</phone>
      <email>bakerdj@peds.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Silvia Delgado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Healthcare System</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belkis Wandique</last_name>
      <phone>954-265-3076</phone>
      <email>bwandiquerapalo@mhs.net</email>
    </contact>
    <investigator>
      <last_name>Herschel Scher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nemours Childrens Specialty Care</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Betty DeLuca</last_name>
      <phone>904-697-3804</phone>
      <email>Elizabeth.deluca@nemours.org</email>
    </contact>
    <investigator>
      <last_name>David Schaeffer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami Bachelor Children's Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alejandra Weisman</last_name>
      <phone>305-243-1425</phone>
      <email>a.weisman1@miami.edu</email>
    </contact>
    <investigator>
      <last_name>Andrew Colin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami School of Medicine Hospital Doctor's Office West</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carolina Aguiar</last_name>
      <phone>305-243-5545</phone>
      <email>Caguiar2@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Matthias Salathe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Florida Pulmonary Group</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenneth Kesser</last_name>
      <phone>407-841-1100</phone>
      <phone_ext>118</phone_ext>
      <email>bkesser@cfpulmonary.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Layish, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arnold Palmer Hospital Pulmonary and Sleep Medical Institute Orlando Health, Inc</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Tilme</last_name>
      <phone>321-843-5278</phone>
      <email>Linda.Tilme@orlandohealth.com</email>
    </contact>
    <investigator>
      <last_name>Luis Faverio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32827</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Germaine Wezel</last_name>
      <phone>407-650-7964</phone>
      <email>Germaine.wezel@nemours.org</email>
    </contact>
    <investigator>
      <last_name>Shatha Yousef, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins All Children's Hospital</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Hodge</last_name>
      <phone>727-767-6881</phone>
      <email>Dhodge6@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Deanna Green, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Health Care of Atlanta at Scottish Rite</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kerry Dibenardo</last_name>
      <phone>404-785-2942</phone>
      <email>Kerry.Dibenardo@choa.org</email>
    </contact>
    <investigator>
      <last_name>Kevin Kirchner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chicago CF Care Specialists</name>
      <address>
        <city>Glenview</city>
        <state>Illinois</state>
        <zip>60025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Congiusti</last_name>
      <phone>847-998-3434</phone>
      <email>Chris@wecare4lungs.com</email>
    </contact>
    <investigator>
      <last_name>Steven Boas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NorthSurburban Pulmonary Specialists</name>
      <address>
        <city>Morton Grove</city>
        <state>Illinois</state>
        <zip>60053</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suellen Moen</last_name>
      <phone>847-738-7334</phone>
      <email>suellen.moen@advocatehealth.com</email>
    </contact>
    <investigator>
      <last_name>Arvey Stone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Riley Hospital for Children at Indiana University Health</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa France</last_name>
      <phone>317-944-3380</phone>
      <email>lfrance@iupui.edu</email>
    </contact>
    <investigator>
      <last_name>Clement Ren, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa Department of Pediatrics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tyler Farber</last_name>
      <phone>319-384-7546</phone>
      <email>tyler-farber@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Ahrens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kansas</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Schooley</last_name>
      <phone>913-588-1572</phone>
      <email>aschooley@kumc.edu</email>
    </contact>
    <investigator>
      <last_name>Joel Mermis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Via Christi Health Systems CF Clinic</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sheri Miller</last_name>
      <phone>316-268-6028</phone>
      <email>sheri.miller@viachristi.org</email>
    </contact>
    <investigator>
      <last_name>Natalie Sollo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville Kosair Charities Pediatric Clinical Research Unit</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Molly Harper, BA, CCRC</last_name>
      <phone>502-629-4695</phone>
      <email>mrharp02@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Ronald Morton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maine Medical Partners Pediatric Specialty Care</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carrie Milliard</last_name>
      <phone>207-662-6712</phone>
      <email>millic@mmc.org</email>
    </contact>
    <investigator>
      <last_name>Colby Wyatt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Carpino</last_name>
      <phone>617-355-2446</phone>
      <email>Elizabeth.carpino@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory Sawicki, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Kruse</last_name>
      <phone>734-615-3266</phone>
      <email>dmkruse@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Samya Nasr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wayne State University (HUH)</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Van Wagnen</last_name>
      <phone>313-745-4737</phone>
      <email>cvanwag@med.wayne.edu</email>
    </contact>
    <investigator>
      <last_name>Ibrahim Abdulamid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Health Care</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Mills</last_name>
      <phone>612-813-7756</phone>
      <email>Anne.mills@childrensmn.org</email>
    </contact>
    <investigator>
      <last_name>Brooke Moore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Mercy</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rose Thompson</last_name>
      <phone>816-302-3377</phone>
      <email>rtthompson@cmh.edu</email>
    </contact>
    <investigator>
      <last_name>Hugo Escobar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardinal Glennon Children's Hospital /Saint Louis University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce L. Hoffman, RN, BSN, CCM</last_name>
      <phone>314-678-5457</phone>
      <email>joyce.hoffmann@health.slu.edu</email>
    </contact>
    <investigator>
      <last_name>Gary Albers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irma Bauer</last_name>
      <phone>314-747-2940</phone>
      <email>irmabauer@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Jeff Atkinson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toni Blazek</last_name>
      <phone>402-708-2785</phone>
      <email>tblazek@unmc.edu</email>
    </contact>
    <investigator>
      <last_name>John Colombo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deb Connolly</last_name>
      <phone>973-971-5138</phone>
      <email>nancy.martinez@atlantichealth.org</email>
    </contact>
    <investigator>
      <last_name>Stanley Fiel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rutgers-Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julianne Wilson</last_name>
      <phone>732-235-5108</phone>
      <email>wilsonj6@rwjms.rutgers.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Scanlin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of New Mexico Pediatric/Pulmonary</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abby Redway</last_name>
      <phone>505-917-3429</phone>
      <email>ajredway@salud.unm.edu</email>
    </contact>
    <investigator>
      <last_name>Hengameh Raissy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albany Medical College</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Denero</last_name>
      <phone>518-262-7851</phone>
      <email>deneroa@mail.amc.edu</email>
    </contact>
    <investigator>
      <last_name>Thomas Smith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health, Div of Pulmonary, Critical Care &amp; Sleep Medicine</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen O'Connor</last_name>
      <phone>516-465-5400</phone>
      <email>Koconnor6@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Joan DeCelie-Germana, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Kramer</last_name>
      <phone>212-305-4675</phone>
      <email>ark2187@columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Emily DiMango, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gloria Pinero</last_name>
      <phone>919-684-2281</phone>
      <email>Gloria.pinero@dm.duke.edu</email>
    </contact>
    <investigator>
      <last_name>Mai ElMallah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest School of Medicine</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryn Kennedy</last_name>
      <phone>336-713-8559</phone>
      <email>klkenned@wakehealth.edu</email>
    </contact>
    <investigator>
      <last_name>Victor Ortega, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Akron Children's Hospital</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Ouellette</last_name>
      <phone>330-543-3089</phone>
      <email>douellette@akronchildrens.org</email>
    </contact>
    <investigator>
      <last_name>Greg Omlor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacey Niehaus, MA, CCRP</last_name>
      <phone>513-803-0762</phone>
      <email>stacey.niehaus@cchmc.org</email>
    </contact>
    <investigator>
      <last_name>John Clancy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittany Consiglio</last_name>
      <phone>216-844-8270</phone>
      <email>Brittany.Consiglio@UHhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Ross Myers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Research Institute at Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Raterman</last_name>
      <phone>614-722-4758</phone>
      <email>laura.raterman@nationwidechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Karen McCoy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dayton Children's Hospital</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandy Bartosik</last_name>
      <phone>937-641-4004</phone>
      <email>bartosiks@childrensdayton.org</email>
    </contact>
    <investigator>
      <last_name>Gary Mueller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toledo Children's Hospital CF Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Hoot</last_name>
      <phone>419-291-4630</phone>
      <email>Kelly.Hoot@promedica.org</email>
    </contact>
    <investigator>
      <last_name>Bruce Barnett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dr. Santiago Reyes, P.C.</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Orf</last_name>
      <phone>405-945-4495</phone>
      <email>teresaorf@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Santiago Reyes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erika Simeon</last_name>
      <phone>503-494-6180</phone>
      <email>simeon@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Alexandra Cornell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Children's Hospital</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane Kitch</last_name>
      <phone>717-531-5646</phone>
      <email>dkitch@hmc.psu.edu</email>
    </contact>
    <investigator>
      <last_name>Gavin Graff, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria Fleck</last_name>
      <phone>215-662-3115</phone>
      <email>Victoria.fleck@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Daniel Dorgan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh of UPMCU</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rose Lanzo</last_name>
      <phone>412-692-5872</phone>
      <email>rose.lanzo@chp.edu</email>
    </contact>
    <investigator>
      <last_name>Mark Dovey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina (MUSC)</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Palmer</last_name>
      <phone>843-792-3169</phone>
      <email>palmerju@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Patrick Flume, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanford Childrens Specialty Clinic</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allisa Richter, RN</last_name>
      <phone>605-328-1387</phone>
      <email>Allisa.Richter@SanfordHealth.org</email>
    </contact>
    <investigator>
      <last_name>Chuanpit Moser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Tennessee Childrens Hosp</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37916</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UTHSC Lebonher Childrens Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathy Horobetz</last_name>
      <phone>901-287-6483</phone>
      <email>chorobet@uthsc.edu</email>
    </contact>
    <investigator>
      <last_name>Tonia Gardner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Children's Chest Associates</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78723</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen Millian</last_name>
      <phone>512-380-9200</phone>
      <phone_ext>65343</phone_ext>
      <email>CaMillian@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Bennie McWilliams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Medical Center Cystic Fibrosis Clinic</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniyal Kamal</last_name>
      <phone>214-456-5489</phone>
      <email>Daniyal.Kamal@childrens.com</email>
    </contact>
    <investigator>
      <last_name>Preeti Sharma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cook Children Medical Center</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Urbanek</last_name>
      <phone>682-885-1244</phone>
      <email>Heather.urbanek@cookchildrens.org</email>
    </contact>
    <investigator>
      <last_name>Karen Schultz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen Edwards</last_name>
      <phone>832-822-4772</phone>
      <email>exedward@texaschildrens.org</email>
    </contact>
    <investigator>
      <last_name>Michelle Mann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Health Science Center at San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin Tragus</last_name>
      <phone>210-567-5262</phone>
      <email>tragus@uthscsa.edu</email>
    </contact>
    <investigator>
      <last_name>Donna Willey-Courand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Tyler</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Garza</last_name>
      <phone>903-877-5435</phone>
      <email>Elizabeth.garza@uthct.edu</email>
    </contact>
    <investigator>
      <last_name>Rodolfo Amaro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah Health Sciences Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Vroom</last_name>
      <phone>801-587-7458</phone>
      <email>Jane.vroom@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Ted Liou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Vermont Medical Center Vermont Lung Center</name>
      <address>
        <city>Colchester</city>
        <state>Vermont</state>
        <zip>05446</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Sweet</last_name>
      <phone>802-847-7958</phone>
      <email>Julie.sweet@uvmhealth.org</email>
    </contact>
    <investigator>
      <last_name>Charlotte Teneback, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System, Cystic Fibrosis Center</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christie L. Aderholt, RN, BSN</last_name>
      <phone>434-297-7773</phone>
      <email>cla6e@virginia.edu</email>
    </contact>
    <investigator>
      <last_name>Deborah Froh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Childrens Hospital of The King's Daughters</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Parrot</last_name>
      <phone>757-668-8244</phone>
      <email>Jennifer.Parrott@chkd.org</email>
    </contact>
    <investigator>
      <last_name>Laura Sass, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Childrens Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon McNamara</last_name>
      <phone>206-987-3921</phone>
      <email>sharon.mcnamara@seattlechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Ronald Gibson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Virginia University</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tammy Clark, RN, BSN</last_name>
      <phone>304-293-5264</phone>
      <email>tclark@hsc.wvu.edu</email>
    </contact>
    <investigator>
      <last_name>Kathryn Moffett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Hastings</last_name>
      <phone>414-266-4707</phone>
      <email>phastings@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>Nicholas Antos, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>British Columbia Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3V4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haley Smith</last_name>
      <phone>604-875-2345</phone>
      <phone_ext>7606</phone_ext>
      <email>haley.smith@cw.bc.ca</email>
    </contact>
    <investigator>
      <last_name>Mark Chilvers, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2017</study_first_submitted>
  <study_first_submitted_qc>June 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2017</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

